NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

OpenDoors, a nonprofit aimed at promoting workforce diversity among the Triangle’s life sciences companies through paid internships is launching this week.
Responding to a need for trained technicians in plant agriculture, Durham Tech is launching the Bio-Agricultural Program Readiness Opportunity (BioAg Pro).
Burlington-based Labcorp has partnered with Walgreens to make its Pixel by Labcorp COVID-19 test kit available in drugstores at no cost for people who meet clinical guidelines.
Amgen, which pioneered the use of recombinant DNA technology four decades ago, has broken ground on a $550 million manufacturing plant in Holly Springs.
Seventeen months after negotiating a whopping $4 billion buyout deal with German pharma giant Bayer, AskBio CEO and co-founder Sheila Mikhail says the pioneering gene therapy company is hitting all its targets.
Procter & Gamble Co., the world’s largest maker of packaged consumer goods, will invest $110 million and create 46 jobs as it expands its manufacturing plant in Greensboro.
Durham-based Bioventus has received an FDA OK to market its next-generation pain treatment device, the StimRouter Neuromodulation System.
Business leaders and legislators met at Pitt Community College last week to discuss the college's expanding efforts to grow a skilled regional pharmaceutical manufacturing workforce.
RTP's Biomason has raised $65 million in Series C financing to accelerate development of its technology for growing biocement with bacteria.
Impact investing is on the rise, and local pharmaceutical industry insiders presenting as part of a “who’s who” speaker lineup at LaunchBio’s recent Invest in Cures forum say it’s already paying off.
Over-the-counter pharmaceutical, vitamin, and supplement products manufacturer BestCo has announced plans for a $177 million expansion of its Mooresville manufacturing site, creating 394 jobs.
Here's an overview of some of the life sciences action that continues to build economic momentum in Wilmington and throughout Southeastern North Carolina.
Raleigh-based specialty pharma company BioDelivery Sciences International has entered into a definitive merger agreement with Massachusetts pharma company Collegium Pharmaceutica.
NC BioNetwork is teaming up with biopharmaceutical companies from across the state for an April 21 virtual career fair to run from 3 to 6 p.m.
The North Carolina Biotechnology Center awarded 17 grants and loans totaling $1.3 million to universities, bioscience companies and nonprofit organizations in the second quarter of its fiscal year.
scroll back to top of page